These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34572475)

  • 1. Synthesis and In Vitro Evaluation of Novel Dopamine Receptor D
    Juza R; Stefkova K; Dehaen W; Randakova A; Petrasek T; Vojtechova I; Kobrlova T; Pulkrabkova L; Muckova L; Mecava M; Prchal L; Mezeiova E; Musilek K; Soukup O; Korabecny J
    Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of selective dopamine D₂ receptor ligands using aripiprazole as the lead compound.
    Vangveravong S; Zhang Z; Taylor M; Bearden M; Xu J; Cui J; Wang W; Luedtke RR; Mach RH
    Bioorg Med Chem; 2011 Jun; 19(11):3502-11. PubMed ID: 21536445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
    Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P
    Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.
    Maeda K; Sugino H; Akazawa H; Amada N; Shimada J; Futamura T; Yamashita H; Ito N; McQuade RD; Mørk A; Pehrson AL; Hentzer M; Nielsen V; Bundgaard C; Arnt J; Stensbøl TB; Kikuchi T
    J Pharmacol Exp Ther; 2014 Sep; 350(3):589-604. PubMed ID: 24947465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.
    Chen X; McCorvy JD; Fischer MG; Butler KV; Shen Y; Roth BL; Jin J
    J Med Chem; 2016 Dec; 59(23):10601-10618. PubMed ID: 27805392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity.
    Ananthan S; Saini SK; Zhou G; Hobrath JV; Padmalayam I; Zhai L; Bostwick JR; Antonio T; Reith ME; McDowell S; Cho E; McAleer L; Taylor M; Luedtke RR
    J Med Chem; 2014 Aug; 57(16):7042-60. PubMed ID: 25126833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties.
    Wood MD; Scott C; Clarke K; Westaway J; Davies CH; Reavill C; Hill M; Rourke C; Newson M; Jones DN; Forbes IT; Gribble A
    Eur J Pharmacol; 2006 Sep; 546(1-3):88-94. PubMed ID: 16925992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D
    Free RB; Cuoco CA; Xie B; Namkung Y; Prabhu VV; Willette BKA; Day MM; Sanchez-Soto M; Lane JR; Laporte SA; Shi L; Allen JE; Sibley DR
    Mol Pharmacol; 2021 Oct; 100(4):372-387. PubMed ID: 34353882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic Aripiprazole.
    Klein Herenbrink C; Verma R; Lim HD; Kopinathan A; Keen A; Shonberg J; Draper-Joyce CJ; Scammells PJ; Christopoulos A; Javitch JA; Capuano B; Shi L; Lane JR
    ACS Chem Biol; 2019 Aug; 14(8):1780-1792. PubMed ID: 31339684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands.
    Ge H; Zhang Y; Yang Z; Qiang K; Chen C; Sun L; Chen M; Zhang J
    Bioorg Med Chem; 2019 May; 27(10):2100-2111. PubMed ID: 30981605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-functional selectivity relationship studies of β-arrestin-biased dopamine D₂ receptor agonists.
    Chen X; Sassano MF; Zheng L; Setola V; Chen M; Bai X; Frye SV; Wetsel WC; Roth BL; Jin J
    J Med Chem; 2012 Aug; 55(16):7141-53. PubMed ID: 22845053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active-state model of a dopamine D2 receptor-Gαi complex stabilized by aripiprazole-type partial agonists.
    Kling RC; Tschammer N; Lanig H; Clark T; Gmeiner P
    PLoS One; 2014; 9(6):e100069. PubMed ID: 24932547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro pharmacology of antipsychotics at human dopamine D2 and D3 receptors].
    Tadori Y; Kobayashi H
    Nihon Yakurigaku Zasshi; 2014 Dec; 144(6):265-71. PubMed ID: 25492361
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif.
    Carro L; Raviña E; Domínguez E; Brea J; Loza MI; Masaguer CF
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6059-62. PubMed ID: 19796944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4(1H)-one derivatives as potential MERS-CoV inhibitors.
    Yoon JH; Lee JY; Lee J; Shin YS; Jeon S; Kim DE; Min JS; Song JH; Kim S; Kwon S; Jin YH; Jang MS; Kim HR; Park CM
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126727. PubMed ID: 31624041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors.
    Tadori Y; Forbes RA; McQuade RD; Kikuchi T
    Eur J Pharmacol; 2009 Apr; 607(1-3):35-40. PubMed ID: 19217900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis toward Bivalent Ligands for the Dopamine D
    Qian M; Wouters E; Dalton JAR; Risseeuw MDP; Crans RAJ; Stove C; Giraldo J; Van Craenenbroeck K; Van Calenbergh S
    J Med Chem; 2018 Sep; 61(18):8212-8225. PubMed ID: 30180563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity study of N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptor.
    Shonberg J; Draper-Joyce C; Mistry SN; Christopoulos A; Scammells PJ; Lane JR; Capuano B
    J Med Chem; 2015 Jul; 58(13):5287-307. PubMed ID: 26052807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer.
    Pulido D; Casadó-Anguera V; Pérez-Benito L; Moreno E; Cordomí A; López L; Cortés A; Ferré S; Pardo L; Casadó V; Royo M
    J Med Chem; 2018 Oct; 61(20):9335-9346. PubMed ID: 30257092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.